Bonesupport Holding AB (publ) (BOEUF)
USD 32.16
(0.0%)
USD 32.16
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -149.86 Million SEK | 18.48% |
| 2022 | -183.83 Million SEK | 0.65% |
| 2021 | -185.04 Million SEK | 46.09% |
| 2020 | -343.25 Million SEK | -320.25% |
| 2019 | -81.68 Million SEK | 68.76% |
| 2018 | -261.46 Million SEK | 39.86% |
| 2017 | -434.74 Million SEK | -1267.17% |
| 2016 | -31.79 Million SEK | -430.51% |
| 2015 | -5.99 Million SEK | -112.38% |
| 2014 | 48.41 Million SEK | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q3 | -153.15 Million SEK | -39.31% |
| 2024 Q1 | -170.57 Million SEK | -13.81% |
| 2024 Q2 | -99.18 Million SEK | 41.85% |
| 2023 Q3 | -151.02 Million SEK | -12.24% |
| 2023 Q1 | -174.01 Million SEK | 5.34% |
| 2023 Q2 | -134.56 Million SEK | 22.67% |
| 2023 FY | -149.86 Million SEK | 18.48% |
| 2023 Q4 | -149.86 Million SEK | 0.77% |
| 2022 Q1 | -173.76 Million SEK | 6.1% |
| 2022 Q3 | -194.14 Million SEK | -27.74% |
| 2022 FY | -183.83 Million SEK | 0.65% |
| 2022 Q4 | -183.83 Million SEK | 5.31% |
| 2022 Q2 | -151.97 Million SEK | 12.54% |
| 2021 Q3 | -214.46 Million SEK | 28.59% |
| 2021 FY | -185.04 Million SEK | 46.09% |
| 2021 Q2 | -300.34 Million SEK | 8.7% |
| 2021 Q4 | -185.04 Million SEK | 13.72% |
| 2021 Q1 | -328.94 Million SEK | 4.17% |
| 2020 Q3 | -367.34 Million SEK | 4.15% |
| 2020 Q4 | -343.25 Million SEK | 6.56% |
| 2020 Q1 | -59.97 Million SEK | 26.57% |
| 2020 FY | -343.25 Million SEK | -320.25% |
| 2020 Q2 | -383.26 Million SEK | -539.0% |
| 2019 Q4 | -81.68 Million SEK | 31.13% |
| 2019 FY | -81.68 Million SEK | 68.76% |
| 2019 Q3 | -118.6 Million SEK | 26.43% |
| 2019 Q2 | -161.21 Million SEK | 21.74% |
| 2019 Q1 | -206 Million SEK | 21.21% |
| 2018 Q1 | -397.17 Million SEK | 8.64% |
| 2018 Q2 | -368.35 Million SEK | 7.26% |
| 2018 Q3 | -313.16 Million SEK | 14.98% |
| 2018 Q4 | -261.46 Million SEK | 16.51% |
| 2018 FY | -261.46 Million SEK | 39.86% |
| 2017 FY | -434.74 Million SEK | -1267.17% |
| 2017 Q1 | 301 Thousand SEK | 100.95% |
| 2017 Q2 | -459.49 Million SEK | -152756.48% |
| 2017 Q3 | -476.28 Million SEK | -3.65% |
| 2017 Q4 | -434.74 Million SEK | 8.72% |
| 2016 FY | -31.79 Million SEK | -430.51% |
| 2016 Q1 | 68.88 Million SEK | 0.0% |
| 2016 Q4 | -31.79 Million SEK | 0.0% |
| 2015 FY | -5.99 Million SEK | -112.38% |
| 2014 FY | 48.41 Million SEK | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| American Medical Technologies Inc. | 479.63 Thousand USD | 31346.312% |
| Ansell Limited | -54.99 Million USD | -172.501% |
| Ansell Limited | -55.1 Million USD | -171.991% |
| BG Medicine, Inc. | - USD | Infinity% |
| Biotage AB (publ) | -36.49 Million USD | -310.671% |
| BioLife Sciences Inc. | - USD | Infinity% |
| CB Scientific, Inc. | -105.1 Thousand USD | -142491.958% |
| Psykey, Inc. | 634.59 Thousand USD | 23716.239% |
| ConvaTec Group Plc | 1.2 Billion USD | 112.483% |
| ConvaTec Group Plc | 1.2 Billion USD | 112.465% |
| Encision Inc. | 1.29 Million USD | 11711.359% |
| Golden Valley Development, Inc | - USD | Infinity% |
| Hear AtLast Holdings, Inc. | 2.3 Million USD | 6591.354% |
| Innovative MedTech Inc. | 1.76 Million USD | 8592.318% |
| LifePoint, Inc. | -3.26 Million USD | -4491.484% |
| Medite Cancer Diagnostics, Inc. | 4.9 Million USD | 3155.902% |
| Paradigm Medical Industries, Inc. | 2.16 Million USD | 7031.869% |
| QuantRx Biomedical Corporation | - USD | Infinity% |
| Remedent, Inc. | -43.3 Thousand USD | -345981.193% |
| Reflect Scientific, Inc. | -1.03 Million USD | -14375.61% |
| SmileDirectClub, Inc. | 778.67 Million USD | 119.246% |
| Sector 10, Inc. | 163 Thousand USD | 92042.945% |
| Shandong Weigao Group Medical Polymer Company Limited | -417.55 Million USD | 64.108% |
| SheerVision, Inc. | 57.34 Thousand USD | 261424.522% |
| United Health Products, Inc. | 660.56 Thousand USD | 22787.562% |
| Vasamed, Inc. | 22.12 Thousand USD | 677556.83% |
| Wearable Health Solutions, Inc. | 2.63 Million USD | 5795.725% |
| Yubo International Biotech Limited | 772.27 Thousand USD | 19505.811% |